Zymergen Acquires enEvolv

Ginkgo Bioworks Acquires Zymergen

July 25, 2022

Biotechnology

Ginkgo Bioworks (NYSE: DNA) will acquire Zymergen in an all‑stock transaction valuing Zymergen at about $300 million; Zymergen stockholders will receive 0.9179 Ginkgo shares per Zymergen share and will own ~5.25% of the combined company. The acquisition is intended to integrate Zymergen's automation, software, and data‑science capabilities and biological assets into Ginkgo's horizontal cell‑programming platform to expand capacity, capabilities, and efficiency across multiple end markets.

E Tech Group Acquires E-Volve Systems

March 2, 2023

Engineering Services

E Tech Group, a portfolio company of Falfurrias Capital Partners, has acquired E-Volve Systems, a provider of industrial automation, controls engineering and computer systems validation. The add-on expands E Tech Group's capabilities and presence in the life sciences, food & beverage, and consumer products markets; terms were not disclosed.

Twist Bioscience Acquires iGenomX

June 30, 2021

Biotechnology

Twist Bioscience acquired iGenomX, a developer of high-throughput multiplex NGS library preparation tools, to expand its NGS workflow capabilities and accelerate customer conversion from microarray genotyping to sequencing-based genotyping. The deal consideration was $35 million (combination of cash and Twist stock, plus up to $5 million contingent stock), and Twist expects modest near-term financial impact with incremental revenue from the acquired business in fiscal 2023.

Emergence Acquires MedEvolve

November 11, 2025

Healthcare Services

Emergence, an enterprise backed by The Pritzker Organization, has acquired MedEvolve, an AI-powered revenue cycle automation and analytics provider. The acquisition combines MedEvolve’s Effective Intelligence platform with Emergence’s software expertise and long-term capital to accelerate AI-driven capabilities for healthcare revenue cycle management.

Ginkgo Bioworks Acquires Novogy's Microbial Engineering Platform

December 16, 2020

Biotechnology

Ginkgo Bioworks acquired the main assets of Novogy, Inc., absorbing Novogy's strain assets, IP portfolio, codebase and most of its technical team. The acquisition brings Novogy's expertise in lipid-producing oleaginous yeasts (notably Yarrowia lipolytica) into Ginkgo's cell‑programming platform to accelerate development of bio-based oils, chemicals and materials.

Evolv Acquires Virginia-based EnzoPay

December 3, 2024

Payments & Fintech

Evolv, a payment acceptance solutions provider headquartered in Newburgh, Indiana, has acquired Virginia-based EnzoPay and will rebrand the business as Evolv Mid-Atlantic. The deal strengthens Evolv's distribution network and expands its presence and capabilities across the Mid-Atlantic (Virginia, DC, Maryland, New Jersey).